HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicolas Bauer Selected Research

Histones (Histone)

1/2024Development of Potent Dual BET/HDAC Inhibitors via Pharmacophore Merging and Structure-Guided Optimization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nicolas Bauer Research Topics

Disease

2Neoplasms (Cancer)
01/2024 - 08/2004
1Carcinoma (Carcinomatosis)
01/2024
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2024
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Glioblastoma (Glioblastoma Multiforme)
09/2013
1Melanoma (Melanoma, Malignant)
08/2004
1Disease Progression
08/2004
1Neoplasm Metastasis (Metastasis)
08/2004

Drug/Important Bio-Agent (IBA)

1Histone Deacetylase InhibitorsIBA
01/2024
1Histone Deacetylases (Histone Deacetylase)IBA
01/2024
1Histones (Histone)IBA
01/2024
1Messenger RNA (mRNA)IBA
01/2024
1Proteins (Proteins, Gene)FDA Link
01/2024
1ErbB Receptors (EGF Receptor)IBA
01/2022
1Phosphotransferases (Kinase)IBA
01/2022
1Temozolomide (Temodar)FDA LinkGeneric
09/2013
1Peptides (Polypeptides)IBA
08/2004
1Histocompatibility Antigens Class IIBA
08/2004
1Neoplasm Antigens (Tumor Antigens)IBA
08/2004

Therapy/Procedure

3Therapeutics
01/2024 - 08/2004
1Radiotherapy
09/2013